Bronhoton syrup 125ml

$3.45

Bronhoton syrup 125ml

Quantity:

SKU: 1805840825 Categories: , , Tags: ,

Description

Composition
Active substance:
1 vial of syrup contains: glaucine hydrobromide – 0.125 g, ephedrine hydrochloride, 0.100 g, basil oil ordinary – 0,125 g
Excipients:
Citric acid monohydrate – 0,125 g sucrose – 43.750 g sodium methyl parahydroxybenzoate – 0.150 g sodium propyl parahydroxybenzoate – 0.025 g polysorbate 80 – 1.250 g ethanol 96% – 1,500 g, water – up to 125 g
Description:
Syrupy liquid yellowish-brown color with a characteristic smell.
Product form:
Syrup.
125 g of PET vials.
1 bottle with instructions for use in a cardboard package.
Contraindications
Increased sensitivity to the drug. Deficiency of sucrase / isomaltase, fructose intolerance, glucose-galactose malabsorption (due sucrose content in the formulation). Coronary heart disease, arterial hypertension, cardiac insufficiency ,, arrhythmia, coronary atherosclerosis, pheochromocytoma, thyrotoxicosis, angle-closure glaucoma, diabetes, hyperthyroidism, prostatic hyperplasia, insomnia, pregnancy, lactation, children under 3 years, with the forthcoming general anesthesia cyclopropane or galotonom.
Carefully.
Patients who are prone to development of drug dependency; patients with liver disease, alcoholism, epilepsy, brain disease, traumatic brain injury; children.
Dosage
1 mg + 0.8 mg
Indications
In the treatment of respiratory diseases, accompanied by dry cough, acute and chronic bronchitis, tracheobronchitis, bronchial asthma, whooping cough.
Interaction with other drugs
BRONHOTON can be used simultaneously with antibiotics, antipyretics and vitamins.
Part of the ephedrine drug weakens the effects of narcotic and hypnotic drugs. When applied simultaneously with cardiac glycosides, certain sympathomimetics, quinidine, tricyclic antidepressants are at risk of arrhythmias.
Side effects can be observed while the use of oxytocin or formulations containing ergot alkaloids.
Combination BRONHOTON – monoamine oxidase inhibitors (MAOIs) can be a headache, increased risk of arrhythmias, hypertensive crisis, cerebral hemorrhage. Receiving BRONHOTON drug is possible only 2 weeks after discontinuation of MAO inhibitors.
BRONHOTON reduce the hypotensive effect of simpatolitikov due to the sympathomimetic action of ephedrine.
When the joint application BRONHOTON preparation with nonselective beta-blockers reduced bronchodilator effect BRONHOTON drug and the antihypertensive effect of beta-blockers.
With simultaneous application of the drug to the hypoglycemic agents for oral or insulin may decrease hypoglycemic effect.
Combination BRONHOTON – dexamethasone – Reduces the therapeutic effect of dexamethasone.
BRONHOTON not recommended to use simultaneously with expectorants (ambroxol, bromhexine, N-acetylcysteine) – due to the difficulty of expectoration of sputum.
During reception BRONHOTONA advised not to take drugs, urine alkalizing such as sodium bicarbonate.
With the simultaneous use of the drug BRONHOTON with drugs that stimulate the central nervous system (CNS), or soft drinks of vegetable origin (coffee, tea, cola) may increase the incentive effect of the drug on the central nervous system.
Overdose
Symptoms include nausea, vomiting, loss of appetite, agitation, poor circulation, limb tremor, dizziness, sweating, difficulty urinating.
Treatment: gastric lavage, activated charcoal, hereinafter shown symptomatic treatment.
pharmachologic effect
Pharmacological group:
Antitussive combined means (centrally acting antitussive + sympathomimetic agent).
Pharmacodynamics:
BRONHOTON – combined formulation of plant origin, and has antitussive bronchodilatory effect. Glaucine suppresses the cough center, without, however, respiratory depression, constipation and the development of drug dependence.
Ephedrine stimulating the respiratory center, bronchi and extends (due to the vasoconstrictive action) eliminates the edema of the bronchial mucosa. Basil oil has a sedative (weak), antimicrobial and spasmolytic effect.
Pharmacokinetics:
Glaucine hydrobromide and hydrochloride ephedrine well absorbed in the digestive tract, creating and maintaining the required therapeutic plasma levels. It stands out, mainly in the urine.
Conditions of supply of pharmacies
On prescription.
side effects
Cardio – vascular system: tachycardia, arrythmia, increased blood pressure.
From the nervous system: tremor, agitation, insomnia, dizziness.
From the digestive system: nausea, vomiting, loss of appetite and constipation.
On the part of the endocrine system, increased libido, dysmenorrhea.
From the urinary system: difficulty urinating, urinary retention in patients with prostatic hyperplasia.
Skin and mucous membranes: rash, increased sweating.
Allergic reactions: urticaria, bronchospasm, urticaria.
Other: impaired vision, tachyphylaxis.
Children – drowsiness.
special instructions
Because of the stimulating action on the central nervous system and possible sleep disturbance is not suitable for receiving BRONHOTON syrup after 16 hours. If after 5-7 days after the start of treatment the symptoms persist or the condition worsens, consult a doctor.
BRONHOTON contains up to about 1.7. % Ethanol. Single dose for children from 3 to 10 years (5 ml) contains up to 0.069 g of alcohol daily dose to 0.20 g dose for children older than 10 years (10 ml) containing up to 0.138 grams of alcohol, a daily dose to 0 , 40, the dose for adults (15 ml) containing up to 0.207 grams of alcohol, a daily dose to 0.60 g
Syrup contains as auxiliary substances methyl and propyl parahydroxybenzoate, which, though rare, can cause urticaria, reactions to immediate-type hypersensitivity urticarial rash and bronchospasm.
The content of ephedrine in the product can give a positive result in doping sample in athletes.
Effects on ability to drive vehicles and management mechanisms.
The drug is not recommended for use in the performance of potentially hazardous activities that require high concentration of attention; psychomotor speed reactions.
Storage conditions
In a dry, dark place at a temperature of 15 – 25 ° C
Keep out of the reach of children!.
Dosing and Administration
Inside.
Adults – 1 tablespoon 3-4 times a day.
Children from 3 to 10 years – 1 teaspoon 3 times a day.
Children older than 10 years – 2 teaspoons 3 times a day.
Duration of treatment is 5-7 days.
Information
Appearance may differ from that depicted in the picture. There are contraindications. You need to read the manual or consult with a specialist

Additional information

Weight0.100 kg
Manufacturer

DOMINANT

There are no reviews yet.

Add your review